Teriparatide therapy for alendronate-associated osteonecrosis of the jaw

New England Journal of Medicine

Volumn 363, Issue 25, 2010, Pages 2473-2474

  Cheung, Ada ^a   Seeman, Ego ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CARBONATE; COLECALCIFEROL; DENOSUMAB; PARATHYROID HORMONE[1-34]; PREDNISOLONE;

AGED; ASTHMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DEBRIDEMENT; DRUG CONTRAINDICATION; FEMALE; HUMAN; JAW OSTEONECROSIS; LETTER; OFF LABEL DRUG USE; PRIORITY JOURNAL; TOOTH EXTRACTION;

EID: 78650228126     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1002684     Document Type: Letter

References (5)

1. Taylor KH, Middlefell LS, Mizen KD. Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br J Oral Maxillofac Surg 2010;48:221-3.
2. Galluzzo S, Santini D, Vincenzi B, et al. Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity. Expert Opin Ther Targets 2007;11:941-54. (Pubitemid 47054489)
3. Terauchi M, Li JY, Bedi B, et al. T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling. Cell Metab 2009;10:229-40.
4. Harper RP, Fung E. Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg 2007;65:573-80. (Pubitemid 46343587)
5. Lau AN, Adachi JD. Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol 2009;36:1835-7.